Researcher.Life Logo

Journal of Hepatology : Impact Factor & More

eISSN: 1600-0641pISSN: 0168-8278

Key Metrics

CiteScore
39.2
Eigenfactor
0.05 - 0.1
Impact Factor
>= 25
Scite Index
0.87 5-Year SI
SJR
Q1Hepatology
SNIP
6.27
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Hepatology

Journal of Hepatology Journal Specifications

Overview
Publisher ELSEVIER
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1985
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Hepatology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Hepatology

Reply to: "Early Abstinence, Socioeconomic Barriers, and Survival in Decompensated Alcohol-Related Cirrhosis: A Real-World Cohort from China".
  • 12 May 2026
  • Journal of hepatology
Rifaximin ameliorates cirrhotic portal hypertension through suppression of microbiome-derived deoxycholic acid.
  • 11 May 2026
  • Journal of hepatology
Arachidonoyl-taurine is elevated in human MASLD and protects against hepatic steatosis and inflammation in preclinical models.
  • 9 May 2026
  • Journal of hepatology
Extracorporeal xenogeneic liver support: Defining the first clinical niche.
  • 7 May 2026
  • Journal of hepatology
A Multi-Analyte cfDNA-based Blood Test for Early Detection of Hepatocellular Carcinoma.
  • 6 May 2026
  • Journal of hepatology
Reply to Goldberg and Tapper Refining ACLF diagnosis: Beyond the scorecard.
  • 5 May 2026
  • Journal of hepatology
Reply to: "Early Abstinence, Socioeconomic Barriers, and Survival in Decompensated Alcohol-Related Cirrhosis: A Real-World Cohort from China".
  • 12 May 2026
  • Journal of hepatology
Rifaximin ameliorates cirrhotic portal hypertension through suppression of microbiome-derived deoxycholic acid.
  • 11 May 2026
  • Journal of hepatology
Arachidonoyl-taurine is elevated in human MASLD and protects against hepatic steatosis and inflammation in preclinical models.
  • 9 May 2026
  • Journal of hepatology
Extracorporeal xenogeneic liver support: Defining the first clinical niche.
  • 7 May 2026
  • Journal of hepatology
A Multi-Analyte cfDNA-based Blood Test for Early Detection of Hepatocellular Carcinoma.
  • 6 May 2026
  • Journal of hepatology
Reply to Goldberg and Tapper Refining ACLF diagnosis: Beyond the scorecard.
  • 5 May 2026
  • Journal of hepatology

FAQs on Journal of Hepatology